In late November, the U.S. Department of Justice (on behalf of the U.S. Food and Drug Administration [FDA]) filed a permanent injunction request against a Pennsylvania supplement maker for failing to comply with its good manufacturing practices (GMPs) regulations. According to a press statement, this is the first time the agency has taken action like this against a supplement manufacturer of this size.
Las Vegas, NV—Three raw materials suppliers were named the winners of the SupplySide West 2011 Scientific Excellence Awards. The tradeshow was held October 10–14, here. The recipients were selected based on their ingredients’ “science/research methods, scientific breakthrough, innovation and appeal for the manufacturing community.”
New York, NY—A bioavailable form of vitamin B5 (Pantesin, a form of pantethine, developed by Kyowa Hakko USA) may help reduce cholesterol levels within the body and help prevent cardiovascular diseases according to research. Published in Nutrition Research Journal, the experiment yielded positive results for those who included pantethine in their diets.
A 23-person clinical trial conducted at Laval University in Quebec, Canada, has confirmed that brown seaweed (InSea2, innoVactiv, Inc., based in Quebec, Canada) positively affects glucose and insulin levels after eating.
A branded cranberry extract (PACran from Decas Botanical Synergies) was showed in a clinical trial to help prevent urinary tract infections (UTIs) in women. Results from the study were presented at the most recent PhytoPharm conference in Nuremberg.